Description
Recombinant monoclonal antibody to OPGL. Manufactured using AbAbТs Recombinant Platform with variable regions (i.e. specificity) from the hybridoma 18B2. This is a reformatted human IgG1 Fc SilentЩ antibody, based on the original human IgG1 format, created for improved compatibility with existing reagents, assays and techniques.
Target
OPGL
Target Alias Names
CD254, Tumor necrosis factor ligand superfamily member 11, TNFSF11, TNF superfamily member 11, Osteoclast differentiation factor, ODF, Osteoprotegerin ligand, OPGL, OPTB2, Receptor activator of nuclear factor kappa-B ligand, RANKL, hRANKL2, TNF-related activation-induced cytokine, TRANCE, sOdf, TNLG6B
Isotype/Mimetic
IgG1
Animal-Derived Biomaterials Used
No
Sequence Available
No
Original Discovery Information Provided On Datasheet
Yes
Antibody/Binder Origins
Animal-free discovery, Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression